DHX9 and hepatocellular carcinoma: DHX9 is overexpressed in a number of cancers, including small cell lung cancer, colorectal cancer, and hepatocellular carcinoma (33, 34, 35, 36, 37, 38), suggesting that DHX9 may represent a novel target for cancer therapy.